{
  "id": 19888780,
  "title": "Injectable Nanobody Wins FDA Approval for Myasthenia Gravis",
  "url": "https://urgent.news/2026/11/13/injectable-nanobody-wins-fda-approval-for-myasthenia-gravis",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-11-13T22:24:00.000Z",
  "source": {
    "name": "MedPage Today",
    "slug": "medpage-today",
    "url": "https://www.medpagetoday.com/neurology/generalneurology/123885"
  },
  "original_language": "en",
  "account": null,
  "summary": "(MedPage Today) -- The FDA on Friday approved injectable gefurulimab (Klygefa), a dual-binding nanobody that blocks complement component 5 (C5) activation, to treat generalized myasthenia gravis in adults who are anti-acetylcholine receptor (AChR...",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}